Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study
Authors
Keywords
-
Journal
LANCET ONCOLOGY
Volume 22, Issue 12, Pages 1777-1786
Publisher
Elsevier BV
Online
2021-11-13
DOI
10.1016/s1470-2045(21)00546-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neoadjuvant checkpoint blockade for cancer immunotherapy
- (2020) Suzanne L. Topalian et al. SCIENCE
- Interleukin-2 chronotherapy for metastatic renal cell carcinoma: Results of a phase I-II study
- (2020) Giovanni Lo Re et al. CYTOKINE
- Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non–Small-Cell Lung Cancer
- (2020) Shirish Gadgeel et al. JOURNAL OF CLINICAL ONCOLOGY
- Circadian rhythm influences induction of trained immunity by BCG vaccination
- (2020) L. Charlotte J. de Bree et al. JOURNAL OF CLINICAL INVESTIGATION
- Blockade of immune checkpoints in lymph nodes through locoregional delivery augments cancer immunotherapy
- (2020) David M. Francis et al. Science Translational Medicine
- Glucocorticoids Regulate Circadian Rhythm of Innate and Adaptive Immunity
- (2020) Akihiro Shimba et al. Frontiers in Immunology
- Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy
- (2020) Zachary S Buchwald et al. Journal for ImmunoTherapy of Cancer
- Addition of chemotherapy to local therapy in women aged 70 years or older with triple-negative breast cancer: a propensity-matched analysis
- (2020) Jennifer A Crozier et al. LANCET ONCOLOGY
- Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy
- (2019) Imran Siddiqui et al. IMMUNITY
- Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors
- (2019) Maddalena Centanni et al. CLINICAL PHARMACOKINETICS
- Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2019) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daylight Saving Time and Artificial Time Zones – A Battle Between Biological and Social Times
- (2019) Till Roenneberg et al. Frontiers in Physiology
- Molecular mechanisms and physiological importance of circadian rhythms
- (2019) Alina Patke et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Circadian rhythms in adaptive immunity
- (2019) Polly Downton et al. IMMUNOLOGY
- Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy
- (2018) F. Stephen Hodi et al. JOURNAL OF CLINICAL ONCOLOGY
- Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
- (2018) Hussein A. Tawbi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
- (2018) Luis Paz-Ares et al. NEW ENGLAND JOURNAL OF MEDICINE
- Concurrent versus non-concurrent immune checkpoint inhibition with stereotactic radiosurgery for metastatic brain disease: a systematic review and meta-analysis
- (2018) Victor M. Lu et al. JOURNAL OF NEURO-ONCOLOGY
- Lymphocyte Circadian Clocks Control Lymph Node Trafficking and Adaptive Immune Responses
- (2017) David Druzd et al. IMMUNITY
- T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
- (2017) Alexander C. Huang et al. NATURE
- Preclinical Pharmacokinetics and Biodistribution Studies of 89 Zr-Labeled Pembrolizumab
- (2016) Christopher G. England et al. JOURNAL OF NUCLEAR MEDICINE
- Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
- (2016) Se Jin Im et al. NATURE
- Morning vaccination enhances antibody response over afternoon vaccination: A cluster-randomised trial
- (2016) Joanna E. Long et al. VACCINE
- Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis
- (2012) S. Giacchetti et al. ANNALS OF ONCOLOGY
- Circadian Variation of the Response of T Cells to Antigen
- (2011) E. E. Fortier et al. JOURNAL OF IMMUNOLOGY
- Cortisol and epinephrine control opposing circadian rhythms in T cell subsets
- (2009) S. Dimitrov et al. BLOOD
- Preliminary evidence that morning vaccination is associated with an enhanced antibody response in men
- (2008) Anna C. Phillips et al. PSYCHOPHYSIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More